89bio, Inc. Proceeds from Stock Options Exercised
89bio, Inc. reported Proceeds from Stock Options Exercised of $59.00 thousand for the 6-month period ending 2025-06-30, per its 10-Q filed 2025-08-08.
Financial Statements › Cash Flow › Financing Activities
us-gaap:ProceedsFromStockOptionsExercised · last filed 2025-08-08
- 89bio, Inc. proceeds from stock options exercised for the quarter ending 2025-06-30 was $26.00K.
- 89bio, Inc. proceeds from stock options exercised for the quarter ending 2025-03-31 was $33.00K, a 68.27% decline year-over-year.
- 89bio, Inc. proceeds from stock options exercised for the quarter ending 2024-12-31 was $99.00K, a 2375.00% increase year-over-year.
- 89bio, Inc. proceeds from stock options exercised for the quarter ending 2024-09-30 was $82.00K, a 29.91% decline year-over-year.
- 89bio, Inc. proceeds from stock options exercised for fiscal 2024 was $242.00K, a 61.77% decline from fiscal 2023.
- 89bio, Inc. proceeds from stock options exercised for fiscal 2023 was $633.00K, a 107.54% increase from fiscal 2022.
- 89bio, Inc. proceeds from stock options exercised for fiscal 2022 was $305.00K.
| Period end | Proceeds from Stock Options Exercised 3 month | Proceeds from Stock Options Exercised 6 month | Proceeds from Stock Options Exercised 9 month | Proceeds from Stock Options Exercised 12 month |
|---|---|---|---|---|
| 2025-06-30 | $26.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-08 | $59.00K 10-Q · filed 2025-08-08 | $158.00K derived: sum of 3 quarters · filed 2025-08-08 | $240.00K derived: sum of 4 quarters · filed 2025-08-08 |
| 2025-03-31 | $33.00K 10-Q · filed 2025-05-02 | $132.00K derived: sum of 2 quarters · filed 2025-05-02 | $214.00K derived: sum of 3 quarters · filed 2025-05-02 | $171.00K derived: sum of 4 quarters · filed 2025-08-08 |
| 2024-12-31 | $99.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $181.00K derived: sum of 2 quarters · filed 2025-02-27 | $138.00K derived: sum of 3 quarters · filed 2025-08-08 | $242.00K 10-K · filed 2025-02-27 |
| 2024-09-30 | $82.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | $39.00K derived: sum of 2 quarters · filed 2025-08-08 | $143.00K 10-Q · filed 2024-11-07 | $147.00K derived: sum of 4 quarters · filed 2025-08-08 |
| 2024-06-30 | -$43.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-08 | $61.00K 10-Q · filed 2025-08-08 | $65.00K derived: sum of 3 quarters · filed 2025-08-08 | $182.00K derived: sum of 4 quarters · filed 2025-08-08 |
| 2024-03-31 | $104.00K 10-Q · filed 2025-05-02 | $108.00K derived: sum of 2 quarters · filed 2025-05-02 | $225.00K derived: sum of 3 quarters · filed 2025-05-02 | |
| 2023-12-31 | $4.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $121.00K derived: sum of 2 quarters · filed 2025-02-27 | $633.00K 10-K · filed 2025-02-27 | |
| 2023-09-30 | $117.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | $629.00K 10-Q · filed 2024-11-07 | ||
| 2023-06-30 | $512.00K 10-Q · filed 2024-08-05 | |||
| 2022-12-31 | $305.00K 10-K · filed 2025-02-27 |